Stem Cell Therapy for Diabetic Peripheral Neuropathy: Pilot Data, Schwann Cell Mechanisms, and the Exosome Shift

Two 2026 systematic reviews, a Schwann cell mechanism study, and the first powered RCT in diabetic peripheral neuropathy — what clinicians need to know about MSC and exosome therapy for DPN.

Lire la suite...

Mesenchymal Stem Cell Therapy in Cervical Cancer: What the 2026 Evidence Shows

A 2026 systematic review found 14 studies of mesenchymal stem cells in cervical cancer, with contradictory results and no study controlling for HPV genotype. Here is what the evidence actually shows.

Lire la suite...

Glycocalyx-Edited MSC Therapy for Advanced Osteoporosis: First-in-Human Trial Results Published in Cell

The first-in-human trial of glycocalyx-edited autologous MSCs shows that engineering bone homing via sLeX expression reduces fragility fractures and increases bone density in advanced osteoporosis patients, with five-plus years of safety data and no serious adverse events.

Lire la suite...
Haut